Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1999 2
2000 1
2003 1
2005 2
2006 1
2009 3
2010 6
2011 6
2012 5
2013 6
2014 4
2015 7
2016 5
2017 8
2018 9
2019 11
2020 11
2021 8
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. Ai D, et al. Mod Pathol. 2021 Apr;34(4):710-719. doi: 10.1038/s41379-020-00692-8. Epub 2020 Oct 3. Mod Pathol. 2021. PMID: 33011748 Free article.
Metaplastic carcinoma of the breast.
McKinnon E, Xiao P. McKinnon E, et al. Arch Pathol Lab Med. 2015 Jun;139(6):819-22. doi: 10.5858/arpa.2013-0358-RS. Arch Pathol Lab Med. 2015. PMID: 26030252 Free article. Review.
Metaplastic Breast Carcinoma: Update on Histopathology and Molecular Alterations.
McMullen ER, Zoumberos NA, Kleer CG. McMullen ER, et al. Arch Pathol Lab Med. 2019 Dec;143(12):1492-1496. doi: 10.5858/arpa.2019-0396-RA. Arch Pathol Lab Med. 2019. PMID: 31765246 Free article. Review.
OBJECTIVE-: To review the histologic classifications, differential diagnosis, prognosis, and recent laboratory studies of metaplastic breast carcinoma. ...
OBJECTIVE-: To review the histologic classifications, differential diagnosis, prognosis, and recent laboratory studies of metaplastic …
Metaplastic breast carcinoma: Analysis of clinical and pathologic features, a five-year study.
Chaudhary D, Balhara K, Mandal S, Mallya V, Tomar R, Khurana N, Bains L. Chaudhary D, et al. J Cancer Res Ther. 2023 Jul-Sep;19(5):1226-1230. doi: 10.4103/jcrt.jcrt_1229_21. J Cancer Res Ther. 2023. PMID: 37787287 Free article. Review.
Other two showed focal sarcomatous and cartilaginous areas in one and angiosarcomatous, bone and cartilage formation admixed with areas of IDC in other case. CONCLUSION: MCB are rare breast tumors with aggressive course and are characterized by their large size and rapid g …
Other two showed focal sarcomatous and cartilaginous areas in one and angiosarcomatous, bone and cartilage formation admixed with areas of I …
Metaplastic breast carcinoma: Current therapeutic approaches and novel targeted therapies.
Drekolias D, Mamounas EP. Drekolias D, et al. Breast J. 2019 Nov;25(6):1192-1197. doi: 10.1111/tbj.13416. Epub 2019 Jun 27. Breast J. 2019. PMID: 31250492 Review.
With the accumulation of knowledge from histopathologic assessment and the increasing identification of underlying molecular aberrations, emerging, novel targeted therapies will enable physicians to implement a more individualized and efficacious therapeutic strategy, leading hop …
With the accumulation of knowledge from histopathologic assessment and the increasing identification of underlying molecular aberrations, em …
Metaplastic breast carcinoma: case series and review of the literature.
Esbah O, Turkoz FP, Turker I, Durnali A, Ekinci AS, Bal O, Sonmez OU, Budakoglu B, Arslan UY, Oksuzoglu B. Esbah O, et al. Asian Pac J Cancer Prev. 2012;13(9):4645-9. doi: 10.7314/apjcp.2012.13.9.4645. Asian Pac J Cancer Prev. 2012. PMID: 23167395 Free article. Review.
In conclusion, MpBC is a rare and orphan disease without standardized treatment approaches and the prognosis is poor so that larger studies to investigate different treatment schedules are urgently needed....
In conclusion, MpBC is a rare and orphan disease without standardized treatment approaches and the prognosis is poor so that larger s …
Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I, Mulita F, Plachouri KM, Benetatos N, Maroulis I, Papadaki H. Akrida I, et al. Med Oncol. 2023 Dec 16;41(1):20. doi: 10.1007/s12032-023-02259-4. Med Oncol. 2023. PMID: 38104042 Review.
This review summarizes the existing literature on the emerging role of EMT in the pathogenesis of MBC and PTs. Both malignant PTs and MBC are characterized by poor prognosis. Therefore, several anti-EMT targeting strategies such as blocking upstream signaling pathways, tar …
This review summarizes the existing literature on the emerging role of EMT in the pathogenesis of MBC and PTs. Both malignant PTs and MBC ar …
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
González-Martínez S, Pérez-Mies B, Pizarro D, Caniego-Casas T, Cortés J, Palacios J. González-Martínez S, et al. Int J Mol Sci. 2021 Jul 9;22(14):7398. doi: 10.3390/ijms22147398. Int J Mol Sci. 2021. PMID: 34299016 Free PMC article. Review.
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with poor prognosis. MBCs have a different clinical behavior from other types of triple negative breast cancer (TNBC), being more resistant to standard chemot …
Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent triple negative (TN) invasive carcinomas with poor prognosis …
100 results